The Saint Francis Hospital and Medical Center’s medical marijuana research program has been approved by the Connecticut Department of Consumer Protection (DCP).

The research program aims to compare the effectiveness of medical marijuana versus oxycodone in patients with chronic pain and post traumatic acute, subacute from multiple rib fractures.

Jonathan A. Harris, consumer protection commissioner said that, “We’re pleased to see our research program move forward so quickly in Connecticut.”

“Our Medical Marijuana Program has already given nearly 15,000 patients relief from severe debilitating conditions, and these research programs will provide medical professionals the information they need to help their patients make good healthcare decisions.”

He expects to see “more thoughtful programs like the one developed at Saint Francis to start here in Connecticut in the coming months, and look forward to the medical progress we can make for families suffering from severe illnesses in the state,” Harris said.

Indian-origin PepsiCo chief Indra Nooyi joins Trump's advisory council!

Nandini